Missouri jury rules in Bayer's favor in Roundup herbicide case
Three women alleged they developed cancer after using the product; it is the first such ruling since the company's Supreme Court victory.
Translated from the Portuguese original by the Panorama newsroom. Read in Portuguese
Summary written by the Panorama newsroom from the sources listed below. Facts are attributed to the original publications.
A jury in the US state of Missouri ruled Thursday (29) in favor of Bayer in a lawsuit brought by three women who said they developed cancer from using the herbicide Roundup, g1 reported, based on Agence France-Presse material.
The plaintiffs allege they have non-Hodgkin lymphoma. The jury rejected the argument that the product had manufacturing defects and should not have been marketed.
According to g1, it is the first ruling of this kind since the US Supreme Court issued an opinion favorable to the company in June. The US environmental agency, the EPA, decided that the product does not need warnings. Executive Bill Dodero said future plaintiffs "will face significant challenges."
Litigation over glyphosate-based herbicides has cost Bayer more than US$ 10 billion since 2018, when it acquired Monsanto. The International Agency for Research on Cancer classifies the substance as probably carcinogenic, but the company cites studies and approval from US and European Union regulators to say it is safe.
Bayer hopes to end the lawsuits through a US$ 7.25 billion class settlement.